BRIDGEWATER, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, wil...…
UZEDY is currently approved in the US as a subcutaneous long-acting injectable (LAI) for use every one or two months for the treatment of schizophrenia in adults1
LAI treatment options may help add...…
LONDON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Malta retains 1st place in the 2025 Global Citizenship Program Index for the 10th consecutive year, while Greece reaches the top of the 2025 Global Reside...…
LONDON and AMSTERDAM, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Hivello, a platform simplifying decentralized node management for non-technical users, and iAgent, an AI agent training platform, are excited to...…
VANCOUVER, British Columbia, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherap...…
VICTORIA, Seychelles, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, has released a report highlighting the transformative impact of artifici...…